Oct. 10, 2025 — Berlin Heals Holding AG, a clinical-stage medical device company focused on revolutionizing the care of heart failure with a first of its kind durable treatment, announced it has completed enrollment in the First-In-Human (FIH) CMIC-III study to evaluate the safety of a new less invasive approach to implanting the Cardiac Microcurrent (CMIC) device. Topline data are expected in 2026 and will be submitted for presentation at a major Cardiology Congress.

Oct. 8, 2025 — Viz.ai recently launched  Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute coronary syndrome (ACS) care team on a single platform, Viz ACS provides Emergency Department (ED) physicians and cardiologists with the same high-quality ECGs and patient data in real time. This streamlined workflow can help improve communication, speeds treatment, and reduces unnecessary cath lab activations.

Oct. 7, 2025 — Cagent Vascular has announced the commercial launch of the Serranator PTA Serration Balloon Catheter in 7.0 mm and 8.0 mm diameters. This expansion brings the proven benefits of serration technology to larger vessels, including the iliac, SFA and other challenging peripheral anatomies.

Oct. 7, 2025 — Nobles Medical Technology II, a provider of  cardiovascular closure solutions, has announced that the U.S. Food and Drug Administration (FDA) has granted approval to restart its NobleStitch clinical trial, marking an important milestone in the development of the first device-free, suture-mediated system for closing patent formaen ovale (PFO) for reduction of recurrent cryptogenic stroke.

Sept. 26, 2025 — A new guideline from the American Society of Echocardiography (ASE) offers updated and expanded recommendations aimed at improving the quality, clarity and consistency of echocardiography reports across diverse clinical settings.